bay y3118 has been researched along with pd 131628 in 1 studies
| Studies (bay y3118) | Trials (bay y3118) | Recent Studies (post-2010) (bay y3118) | Studies (pd 131628) | Trials (pd 131628) | Recent Studies (post-2010) (pd 131628) |
|---|---|---|---|---|---|
| 37 | 0 | 0 | 31 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauernfeind, A | 1 |
1 other study(ies) available for bay y3118 and pd 131628
| Article | Year |
|---|---|
Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1993 |